SK285924B6 - Substituované 3-fenyl-5-alkoxy-1,3,4-oxadiazol-2-óny, spôsob ich prípravy, liečivo s ich obsahom a ich použitie - Google Patents

Substituované 3-fenyl-5-alkoxy-1,3,4-oxadiazol-2-óny, spôsob ich prípravy, liečivo s ich obsahom a ich použitie Download PDF

Info

Publication number
SK285924B6
SK285924B6 SK301-2002A SK3012002A SK285924B6 SK 285924 B6 SK285924 B6 SK 285924B6 SK 3012002 A SK3012002 A SK 3012002A SK 285924 B6 SK285924 B6 SK 285924B6
Authority
SK
Slovakia
Prior art keywords
alkyl
substituted
group
phenyl
oxadiazol
Prior art date
Application number
SK301-2002A
Other languages
English (en)
Slovak (sk)
Other versions
SK3012002A3 (en
Inventor
Stefan Petry
Karl Schoenafinger
Guenter Mueller
Karl-Heinz Baringhaus
Original Assignee
Sanofi-Aventis Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis Deutschland Gmbh filed Critical Sanofi-Aventis Deutschland Gmbh
Publication of SK3012002A3 publication Critical patent/SK3012002A3/sk
Publication of SK285924B6 publication Critical patent/SK285924B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
SK301-2002A 1999-09-04 2000-08-22 Substituované 3-fenyl-5-alkoxy-1,3,4-oxadiazol-2-óny, spôsob ich prípravy, liečivo s ich obsahom a ich použitie SK285924B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19942354A DE19942354A1 (de) 1999-09-04 1999-09-04 Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneimitteln
PCT/EP2000/008150 WO2001017981A1 (de) 1999-09-04 2000-08-22 Substituierte 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one und ihre verwendung als lipase-hemmer

Publications (2)

Publication Number Publication Date
SK3012002A3 SK3012002A3 (en) 2002-06-04
SK285924B6 true SK285924B6 (sk) 2007-11-02

Family

ID=7920884

Family Applications (1)

Application Number Title Priority Date Filing Date
SK301-2002A SK285924B6 (sk) 1999-09-04 2000-08-22 Substituované 3-fenyl-5-alkoxy-1,3,4-oxadiazol-2-óny, spôsob ich prípravy, liečivo s ich obsahom a ich použitie

Country Status (30)

Country Link
US (1) US6596742B1 (es)
EP (1) EP1214302B1 (es)
JP (1) JP2003508522A (es)
KR (1) KR100723817B1 (es)
CN (1) CN1152024C (es)
AR (1) AR032430A1 (es)
AT (1) ATE253059T1 (es)
AU (1) AU781330B2 (es)
BR (1) BR0013765A (es)
CA (1) CA2383731A1 (es)
CZ (1) CZ2002772A3 (es)
DE (2) DE19942354A1 (es)
DK (1) DK1214302T3 (es)
EE (1) EE04811B1 (es)
ES (1) ES2204685T3 (es)
HK (1) HK1048318B (es)
HR (1) HRP20020187A2 (es)
HU (1) HUP0202988A3 (es)
IL (2) IL148275A0 (es)
MX (1) MXPA02001834A (es)
NO (1) NO323129B1 (es)
NZ (1) NZ517551A (es)
PL (1) PL197314B1 (es)
PT (1) PT1214302E (es)
RU (1) RU2265600C2 (es)
SK (1) SK285924B6 (es)
TR (1) TR200200553T2 (es)
WO (1) WO2001017981A1 (es)
YU (1) YU10402A (es)
ZA (1) ZA200201594B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10102265C1 (de) * 2001-01-18 2002-08-08 Aventis Pharma Gmbh Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneistoffen
DE10208986A1 (de) * 2002-02-28 2003-09-11 Aventis Pharma Gmbh Verwendung substituierter 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one zur Herstellung von Arzneimitteln mit hemmender Wirkung an der pankreatischen Lipase
US6900233B2 (en) 2002-02-28 2005-05-31 Aventis Pharma Deutschland Gmbh Substituted 3-phenyl-5-alkoxy-3H-(1,3,4)-oxadiazol-2-ones, pharmaceutical composition and method for treating obesity thereof
DE10208987A1 (de) * 2002-02-28 2003-09-11 Aventis Pharma Gmbh Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxidiazol-2-one, ihre Herstellung und Verwendung in Arzneistoffen
US7208504B2 (en) 2002-10-12 2007-04-24 Sanofi-Aventis Deutschland Gmbh Bicyclic inhibitors of hormone sensitive lipase
DE10247680B4 (de) * 2002-10-12 2005-09-01 Aventis Pharma Deutschland Gmbh Neue bicyclische Inhibitoren der Hormon Sensitiven Lipase
AU2005295788A1 (en) * 2004-10-13 2006-04-27 Wyeth N-benzenesulfonyl substituted anilino-pyrimidine analogs
CN101821227A (zh) * 2007-07-12 2010-09-01 德维里斯公司 激素敏感性脂酶调节剂及使用方法
WO2009084970A1 (en) * 2007-12-27 2009-07-09 Bial-Portela & Companhia, S.A. 5-o-substituted 3-n-phenyl-1,3,4-oxadiazolones for medical use
WO2010074587A2 (en) 2008-12-23 2010-07-01 Bial - Portela & Ca., S.A. 5-o-substituted 3-n-aryl-1,3,4-oxadiazolones for medical use
US8501768B2 (en) * 2011-05-17 2013-08-06 Hoffmann-La Roche Inc. Hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone compounds
CN114163351B (zh) * 2020-09-11 2024-01-23 江苏优嘉植物保护有限公司 噁虫酮中间体2-(2-甲氧基)苯肼甲酸甲酯合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB518042A (en) 1937-09-15 1940-02-15 Ljungstroms Angturbin Ab Improvements in elastic fluid turbines of the double rotation type
FR2299028A1 (fr) 1975-02-03 1976-08-27 Rhone Poulenc Ind Nouvea
US4076824A (en) 1975-02-03 1978-02-28 Rhone-Poulenc Industries Anthelmintic oxadiazolinone derivatives
FR2299328A1 (fr) 1975-02-03 1976-08-27 Rhone Poulenc Ind Derives de l'alcoyloxy-5 phenyl-3 oxyde azo
DK156439C (da) 1980-09-15 1990-01-22 Shell Int Research 7-substituerede 2,3-dihydrobenzofuranderivater samt pesticidpraeparater indeholdende disse og en fremgangsmaade til bekaempelse af skadelige organismer
DE3267258D1 (en) 1981-06-15 1985-12-12 Shell Int Research 7-substituted 2,3-dihydrobenzofurans, their preparation and their use as pesticides or as chemical intermediates
JPS60115502A (ja) * 1983-11-28 1985-06-22 Mitsubishi Chem Ind Ltd 殺虫剤
DE3931843A1 (de) 1989-09-23 1991-04-04 Bayer Ag Substituierte 1,3,4-oxa(thia)diazolinone verfahren zu ihrer herstellung und ihre verwendung der bekaempfung von endoparasiten
US5236939A (en) 1989-09-23 1993-08-17 Bayer Aktiengesellschaft Substituted 1,3,4-oxa(thia)diazolinones process for their preparation and their use of combating endoparasites
US5641796A (en) * 1994-11-01 1997-06-24 Eli Lilly And Company Oral hypoglycemic agents

Also Published As

Publication number Publication date
ZA200201594B (en) 2003-04-30
CA2383731A1 (en) 2001-03-15
SK3012002A3 (en) 2002-06-04
EE04811B1 (et) 2007-04-16
NO323129B1 (no) 2007-01-08
HRP20020187A2 (en) 2004-02-29
HK1048318B (zh) 2004-12-10
IL148275A0 (en) 2002-09-12
EP1214302A1 (de) 2002-06-19
RU2265600C2 (ru) 2005-12-10
MXPA02001834A (es) 2002-08-12
NO20021007D0 (no) 2002-02-28
HUP0202988A3 (en) 2004-12-28
HUP0202988A2 (hu) 2002-12-28
DK1214302T3 (da) 2004-02-16
AR032430A1 (es) 2003-11-12
JP2003508522A (ja) 2003-03-04
CN1152024C (zh) 2004-06-02
ES2204685T3 (es) 2004-05-01
US6596742B1 (en) 2003-07-22
PL353214A1 (en) 2003-11-03
KR20020024336A (ko) 2002-03-29
NO20021007L (no) 2002-02-28
PT1214302E (pt) 2004-03-31
YU10402A (sh) 2004-11-25
AU781330B2 (en) 2005-05-19
TR200200553T2 (tr) 2002-06-21
DE50004274D1 (de) 2003-12-04
AU7411200A (en) 2001-04-10
BR0013765A (pt) 2002-04-30
HK1048318A1 (en) 2003-03-28
PL197314B1 (pl) 2008-03-31
CN1371369A (zh) 2002-09-25
WO2001017981A1 (de) 2001-03-15
DE19942354A1 (de) 2001-03-08
CZ2002772A3 (cs) 2002-05-15
EP1214302B1 (de) 2003-10-29
IL148275A (en) 2008-08-07
EE200200109A (et) 2003-06-16
KR100723817B1 (ko) 2007-06-04
ATE253059T1 (de) 2003-11-15
NZ517551A (en) 2003-10-31

Similar Documents

Publication Publication Date Title
EP3573983B1 (en) N-[4-fluoro-5-[[(2s,4s)-2-methyl-4-[(5-methyl-1,2,4-oxadiazol-3-yl)methoxy]-1-piperidyl]methyl]thiazol-2-yl]acetamide as oga inhibitor
EP3630755B1 (en) 5-methyl-1,3,4-oxadiazol-2-yl compounds
EP1981858B1 (en) 3,5-di(aryl or heteroaryl)isoxazoles and 1,2,4-oxadiazoles as s1p1 receptor agonists, immunosuppresssive and anti-inflammatory agents
KR20060002728A (ko) 벤조티아졸 유도체의 신규한 용도
KR100790763B1 (ko) 치환된 3-페닐-5-알콕시-1,3,4-옥스디아졸-2-온 및 이를 포함하는 호르몬 민감성 리파아제 억제용 약제
SK285924B6 (sk) Substituované 3-fenyl-5-alkoxy-1,3,4-oxadiazol-2-óny, spôsob ich prípravy, liečivo s ich obsahom a ich použitie
JP2003525931A6 (ja) 置換された３−フェニル−５−アルコキシ−１，３，４−オキサジアゾール−２−オンおよびホルモン感受性リパーゼを阻害するためのその使用
KR20090125223A (ko) 3,4-디히드로-벤조[ｅ][1,3]옥사진-2-온
IE66384B1 (en) 3-substituted 1,2,3,4-oxytriazole-5-imine compounds a process for the preparation thereof and a pharmaceutical preparation containing said compounds
US6900233B2 (en) Substituted 3-phenyl-5-alkoxy-3H-(1,3,4)-oxadiazol-2-ones, pharmaceutical composition and method for treating obesity thereof
FI79847B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara akridanon-derivat.
WO2020153432A1 (ja) アミノ酸化合物

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20090822